Amzat Jimoh, Kanmodi Kehinde Kazeem, Aminu Kafayat, Ismail Abbas, Salami Afeez Abolarinwa
Department of Sociology Usmanu Danfodiyo University Sokoto Nigeria.
School of Health and Life Sciences Teesside University Middlesbrough UK.
Public Health Chall. 2024 May 6;3(2):e182. doi: 10.1002/puh2.182. eCollection 2024 Jun.
Health intervention trials constitute important research efforts to find appropriate solutions to health issues affecting different populations. In many cases, it involves high-risk groups such as the trans-communities. This scoping review aims to review the existing health intervention trials involving transgender, transabled and transracial persons in Africa.
This scoping review adopted the research design by Arskey and O'Malley. Using the Population-Concept-Context framework, a robust systematic search of four research databases, including APA PsycINFO, SCOPUS, CINAHL Complete and PubMed, was conducted to retrieve literature relevant to the review's question. Duplicate copies in the retrieved literature were removed using the Rayyan web-based application. The residual literature was screened for relevance based on the review's inclusion and exclusion criteria, and only those eligible articles were included in this review. From the included literature, data were charted, collated, summarized and presented as results.
The scoping review included and reviewed only four articles, which reported studies involving transgender persons. No peer-reviewed original research article on transabled and transracial persons in Africa was found eligible for inclusion in this review. All the reviewed articles focused on at-risk, healthy and human immunodeficiency virus (HIV)-uninfected adult participants ranging between the ages of 18 and 65 years. The domains investigated in those articles were on sexual health, HIV preventive drugs and vaccine trials. The reviewed findings showed the use of HIV-inhibiting medications and HIV screening or testing as vital preventive interventions among transgender persons in Africa. The available research evidence shows sexuality reductionism about trans behaviour by neglecting other health domains.
Health trial research on transracial, transgender and transabled persons is a largely underexplored research domain in Africa. More health intervention trials, beyond the domain of sexual health, are required to improve the health and well-being of this highly marginalized population group in Africa.
健康干预试验是为影响不同人群的健康问题寻找合适解决方案的重要研究工作。在许多情况下，这涉及到跨性别群体等高风险群体。本范围综述旨在回顾非洲现有的涉及跨性别者、跨能力者和跨种族者的健康干预试验。
本范围综述采用了Arskey和O'Malley的研究设计。利用“人群 - 概念 - 背景”框架，对四个研究数据库进行了全面的系统检索，包括美国心理学会心理学文摘数据库（APA PsycINFO）、Scopus数据库、护理学与健康领域数据库（CINAHL Complete）和医学期刊数据库（PubMed），以检索与综述问题相关的文献。使用基于网络的Rayyan应用程序去除检索文献中的重复副本。根据综述的纳入和排除标准对剩余文献进行相关性筛选，只有符合条件的文章才纳入本综述。从纳入的文献中，对数据进行图表绘制、整理、总结并呈现为结果。
该范围综述仅纳入并审查了四篇文章，这些文章报告了涉及跨性别者的研究。未发现关于非洲跨能力者和跨种族者的经同行评审的原创研究文章符合纳入本综述的条件。所有审查的文章都聚焦于年龄在18至65岁之间的高危、健康且未感染人类免疫缺陷病毒（HIV）的成年参与者。这些文章中研究的领域包括性健康、HIV预防药物和疫苗试验。审查结果表明，在非洲的跨性别者中，使用HIV抑制药物以及HIV筛查或检测是重要的预防干预措施。现有研究证据显示，由于忽视其他健康领域，对跨性别行为存在性取向简化论的观点。
在非洲，关于跨种族、跨性别和跨能力者的健康试验研究在很大程度上是一个未充分探索的研究领域。需要开展更多超出性健康领域的健康干预试验，以改善非洲这一高度边缘化人群的健康和福祉。
